Bevacizumab and daily temozolomide for recurrent glioblastoma.
Desjardins A, Reardon DA, Coan A, Marcello J, Herndon JE 2nd, Bailey L, Peters KB, Friedman HS, Vredenburgh JJ.
Desjardins A, et al. Among authors: marcello j.
Cancer. 2012 Mar 1;118(5):1302-12. doi: 10.1002/cncr.26381. Epub 2011 Jul 26.
Cancer. 2012.
PMID: 21792866
Free article.
Clinical Trial.